CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Champalimaud Cancer Center

Academic/Hospital

Also known as: Champalimaud Foundation | Fundacao Champalimaud

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 31, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (6 distinct, 2 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

pembrolizumab

Indications

Studied for

Breast Neoplasms

Recent trials (2)

NCT06371807Lead sponsorPhase 2Jul 31, 2024
NCT00433589Study chairPhase 3Dec 1, 2006

Details

Last known activity: Jul 31, 2024